Aarti Drugs cash flow

Latest FY26

Cash from operations: ₹254cr+3.7% on FY25
Capital spending: ₹173cr−2.2% on FY25
Free cash flow: ₹80.2cr+19.0% on FY25
Cash from financing: −₹77.4cr−₹82.1 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	67.0	55.8	51.5	50.3
	—	−0.5	0.3	−1.8	−1.3
	—	−17.9	13.0	34.3	5.8
	—	−70.0	34.4	161	−93.5
	—	−0.0	−0.3	0.3	0.0
	—	0.0	1.2	0.0	0.0
	—	23.6	−43.7	−92.5	−27.7
	—	3.7	3.7	1.9	0.8
Cash from operating activities
	229	211	212	236	224
	—	5.9	64.3	155	−65.7
	—	217	276	390	158
	—	−1.2	−12.2	−2.5	−0.7
	—	−33.7	−35.9	−33.5	−36.2
	—	0.0	−0.0	0.0	0.0
	—	0.1	−0.0	0.2	−0.1
	—	−4.1	55.1	62.4	59.7
	—	254	245	359	134
Cash from investing activities
	—	173	177	226	165
	—	0.3	0.1	0.2	0.0
	—	0.0	0.3	0.0	0.0
	—	1.6	0.0	0.0	0.0
	—	0.0	0.0	0.0	0.0
	—	1.2	12.2	2.5	0.7
	—	−0.0	0.0	0.0	0.0
	—	−173	−165	−224	−164
Cash from financing activities
	—	0.0	73.2	0.0	0.0
	—	43.0	111	148	60.0
	—	70.0	77.6	45.9	0.0
	—	32.3	33.4	31.3	36.2
	—	18.2	9.1	9.3	9.4
	—	0.0	0.0	−198	2.2
	—	−77.4	−82.1	−136	16.5
	—	2.7	−2.2	−0.8	−13.2
	—	2.7	−2.2	−0.8	−13.2
	—	—	—	6.7	8.4
Reference items
	333	309	287	316	306
	12.4%	12.1%	12.0%	12.5%	11.3%
	80.2	80.2	67.4	133	−30.5
	—	10.5	83.8	57.2	—
	₹8.79	₹8.79	₹7.39	₹14.53	−₹3.34
	51.08×	—	—	—	—
	—	1.30×	1.45×	2.09×	0.81×
	—	−4.1	55.1	62.4	59.7
	—	32.3	33.4	31.3	36.2

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

AARTIDRUGS₹449.00

Aarti Drugs Ltd.

· Pharma & Health

₹ CrorePeersALIVUS AARTIPHARM ADVENZYMES AGARWALEYE AKUMS APLLTD CORONA HCGMcap ₹4,098 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	50.3	51.5	55.8	67.0	—
+ Unrealised FX (Gain) / Loss	-1.3	-1.8	0.3	-0.5	—
Changes in Working Capital
+ Inventories	5.8	34.3	13.0	-17.9	—
+ Trade Receivables — Current	-93.5	161.1	34.4	-70.0	—
+ Other Financial Assets — Non-current	0.0	0.3	-0.3	-0.0	—
+ Other Non-current Assets	0.0	0.0	1.2	0.0	—
+ Trade Payables — Current	-27.7	-92.5	-43.7	23.6	—
+ Provisions — Current	0.8	1.9	3.7	3.7	—
Cash from Operating Activities
Profit Before Tax (per I/S)	224.2	235.5	211.8	210.9	229.0
+ Total Adjustments (incl. Working Capital)	-65.7	154.6	64.3	5.9	—
Cash from Operations (pre-tax)	158.5	390.1	276.1	216.8	—
+ Interest Received — Operating	-0.7	-2.5	-12.2	-1.2	—
+ Interest Paid — Operating	-36.2	-33.5	-35.9	-33.7	—
+ Dividends Received — Operating	0.0	0.0	-0.0	0.0	—
+ Other Inflows / (Outflows) — Operating	-0.1	0.2	-0.0	0.1	—
+ Income Taxes Paid	59.7	62.4	55.1	-4.1	—
Cash from Operating Activities	134.2	358.9	244.6	253.5	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	164.7	226.3	177.2	173.3	—
+ Disp of Fixed Assets	0.0	0.2	0.1	0.3	—
+ Disp of Investment Property	0.0	0.0	0.3	0.0	—
+ Purchase of Investments (Equity / Debt)	0.0	0.0	0.0	1.6	—
+ Dividends Received — Investing	0.0	0.0	0.0	0.0	—
+ Interest Received — Investing	0.7	2.5	12.2	1.2	—
+ Other Inflows / (Outflows) — Investing	0.0	0.0	0.0	-0.0	—
Cash from Investing Activities	-164.0	-223.7	-164.6	-173.4	—
Cash from Financing Activities
+ Buyback / Redemption of Own Shares	0.0	0.0	73.2	0.0	—
+ Proceeds from Borrowings	60.0	148.2	111.2	43.0	—
+ Repayment of Borrowings	0.0	45.9	77.6	70.0	—
+ Interest Paid	36.2	31.3	33.4	32.3	—
+ Dividends Paid	9.4	9.3	9.1	18.2	—
+ Other Inflows / (Outflows) — Financing	2.2	-197.7	0.0	0.0	—
Cash from Financing Activities	16.5	-136.0	-82.1	-77.4	—
Net Changes in Cash (pre-FX)	-13.2	-0.8	-2.2	2.7	—
Net Changes in Cash	-13.2	-0.8	-2.2	2.7	—
Closing Cash	8.4	6.7	—	—	—
Reference Items
EBITDA	305.6	316.5	287.1	309.2	333.3
EBITDA Margin %	11.25	12.52	12.03	12.05	12.45
Free Cash Flow (CFO − Capex)	-30.5	132.6	67.4	80.2	80.2
Free Cash Flow to Equity	—	57.2	83.8	10.5	—
Free Cash Flow per Basic Share	-3.34	14.53	7.39	8.79	8.79
Price to Free Cash Flow	—	—	—	—	51.08
Cash Flow to Net Income	0.81	2.09	1.45	1.30	—
Cash Paid for Taxes	59.7	62.4	55.1	-4.1	—
Cash Paid for Interest	36.2	31.3	33.4	32.3	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.